We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

86 hedge funds and large institutions have $756M invested in Q32 Bio in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 8

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

33% more capital invested

Capital invested by funds: $569M → $756M (+$187M)

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

8% more funds holding

Funds holding: 80 → 86 (+6)

0.64% more ownership

Funds ownership: 3.97% → 4.61% (+0.64%)

97% less call options, than puts

Call options by funds: $28K | Put options by funds: $924K

Holders
86
Holders Change
+6
Holders Change %
+7.5%
% of All Funds
1.69%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.08%
New
19
Increased
27
Reduced
22
Closed
8
Calls
$28K
Puts
$924K
Net Calls
-$896K
Net Calls Change
-$920K

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$30.2M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.17M
3
JP Morgan Chase
JP Morgan Chase
New York
+$1.4M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.13M
5
Millennium Management
Millennium Management
New York
+$905K

Top Sellers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
-$14.8M
2
Citadel Advisors
Citadel Advisors
Florida
-$11.3M
3
DM
Deerfield Management
New York
-$8.19M
4
CAM
Cormorant Asset Management
Massachusetts
-$4.44M
5
GTC
Ghost Tree Capital
New York
-$4.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
5VM
1
5AM Venture Management
California
$115M +$88.1M +307,551 New
DM
2
Deerfield Management
New York
$109M -$8.19M -28,596 -9%
RI
3
RTW Investments
New York
$90M +$30.2M +105,543 +78%
Temasek Holdings
4
Temasek Holdings
Singapore
$66.7M – – –
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$57.5M -$1.99M -6,956 -4%
JP Morgan Chase
6
JP Morgan Chase
New York
$46M +$1.4M +4,871 +4%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$44.9M +$675K +2,357 +2%
BlackRock
8
BlackRock
New York
$44.5M +$185K +646 +0.5%
BG
9
Bellevue Group
Switzerland
$33.4M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$23.6M -$45K -157 -0.2%
State Street
11
State Street
Massachusetts
$17M -$490K -1,710 -4%
VM
12
VV Manager
Massachusetts
$16M – – –
Wellington Management Group
13
Wellington Management Group
Massachusetts
$9.33M +$7.17M +25,042 New
RSCM
14
Rock Springs Capital Management
Maryland
$8.8M – – –
Franklin Resources
15
Franklin Resources
California
$7.52M – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$7.38M +$270K +941 +5%
Victory Capital Management
17
Victory Capital Management
Texas
$7.36M -$438K -1,530 -7%
Northern Trust
18
Northern Trust
Illinois
$6.62M -$265K -927 -5%
GTP
19
Global Thematic Partners
New York
$4.52M – – –
Charles Schwab
20
Charles Schwab
California
$3.14M +$43.2K +151 +2%
EAM
21
Erste Asset Management
Austria
$2.9M – – –
Ameriprise
22
Ameriprise
Minnesota
$2.19M +$69.9K +244 +4%
N
23
Nuveen
North Carolina
$1.94M +$3.44K +12 +0.2%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$1.93M +$51.6K +180 +4%
Allianz Asset Management
25
Allianz Asset Management
Germany
$1.68M +$790K +2,757 +157%
1
2 3 4

QTTB Hedge Fund Activity: Q4 2019 in Review

86 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2019, worth a combined $756M — up 33% from $569M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new QTTB positions and 8 closed out — a net gain of 11 holders — while 27 added to existing stakes and 22 trimmed.

The largest buyer was RTW Investments, adding an estimated $30.2M. The largest seller was Casdin Capital, exiting entirely with an estimated $14.8M sold.

  • 86 institutional investors held Q32 Bio (QTTB) as of Q4 2019, up from 80 in Q3 2019.
  • Funds reported $756M of Q32 Bio stock for Q4 2019, up 33% quarter-over-quarter.
  • 19 funds opened new Q32 Bio positions in Q4 2019 and 8 closed out, a net change of +11 holders.
  • The largest Q32 Bio buyer in Q4 2019 was RTW Investments, an estimated $30.2M added.
  • The largest Q32 Bio seller in Q4 2019 was Casdin Capital, an estimated $14.8M sold.

Based on aggregated 13F filings for Q4 2019.